PAR PHARMACEUTICAL COMPANIES, INC. Future Amortization Expense, Year Two (Deprecated 2012-01-31)
PAR PHARMACEUTICAL COMPANIES, INC. reported Future Amortization Expense, Year Two (Deprecated 2012-01-31) of $33.71 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearTwo · last filed 2012-08-02
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, year two (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $16.41M.
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, year two (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $111.00K.
- PAR PHARMACEUTICAL COMPANIES, INC. future amortization expense, year two (deprecated 2012-01-31) for fiscal 2011 was $23.64M.
| Period end | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 0 month | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 9 month | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|---|
| 2012-06-30 | $33.71M 10-Q · filed 2012-08-02 | ||||
| 2012-03-31 | $33.52M 10-Q · filed 2012-05-08 | ||||
| 2011-12-31 | $16.41M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $16.52M derived: sum of 2 quarters · filed 2012-02-28 | $23.64M 10-K · filed 2012-02-28 | ||
| 2011-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $7.23M 10-Q · filed 2011-11-02 | |||
| 2011-06-30 | $7.12M 10-Q · filed 2011-08-03 |